Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Journal of Comparative Effectiveness Research
|
March 13, 2026
Lefamulin versus omadacycline for community acquired bacterial pneumonia: a systematic review and anchored indirect treatment comparison using moxifloxacin as the common comparator
Meiyu Wu, Sheng Han, Hongchao Li
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|
January 5, 2021
[Progress in human epidermal growth factor research]
Meiyu Wu, Jinghua Ruan, Boxiong Zhong
Metabolic Brain Disease
|
January 10, 2020
Knockdown of IL-32 protects PC12 cells against oxygen-glucose deprivation/reoxygenation-induced injury via activation of Nrf2/NF-κB pathway
Hua Yin, Meiyu Wu, Yue Jia
Autoimmunity
|
March 2, 2021
Immune repertoire: Revealing the "real-time" adaptive immune response in autoimmune diseases
Meiyu Wu, Ming Zhao, Haijing Wu, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
July 10, 2024
Cost-effectiveness analysis of first-line serplulimab plus chemotherapy for advanced squamous non-small-cell lung cancer in China: based on the ASTRUM-004 trial
Heng Xiang, Kehui Meng, Meiyu Wu, et al.
Hematological Oncology
|
July 16, 2026
Cost-Effectiveness of Epcoritamab Plus Lenalidomide and Rituximab Versus Lenalidomide and Rituximab for Relapsed/Refractory Follicular Lymphoma: A US Payer Perspective
Yongtao He, Meiyu Wu, Andong Li, et al.
International Journal of Nanomedicine
|
June 27, 2019
Size-dependent cellular uptake and localization profiles of silver nanoparticles
Meiyu Wu, Hongbo Guo, Lin Liu, et al.
Preventive Medicine
|
January 8, 2024
Personalizing age of gastric cancer screening based on comorbidity in China: Model estimates of benefits, affordability and cost-effectiveness optimization
Shuxia Qin, Xuehong Wang, Sini Li, et al.
Future Oncology (London, England)
|
May 10, 2025
Economic evaluation of Erdafitinib as a second-line treatment for advanced metastatic urothelial carcinoma: real-world data from the USA and prospective analysis from China
Andong Li, Meiyu Wu, Ouyang Xie, et al.
BMC Medicine
|
July 27, 2023
Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study
Meiyu Wu, Shuxia Qin, Chongqing Tan, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Journal of Comparative Effectiveness Research
|
March 13, 2026
Lefamulin versus omadacycline for community acquired bacterial pneumonia: a systematic review and anchored indirect treatment comparison using moxifloxacin as the common comparator
Meiyu Wu, Sheng Han, Hongchao Li
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|
January 5, 2021
[Progress in human epidermal growth factor research]
Meiyu Wu, Jinghua Ruan, Boxiong Zhong
Metabolic Brain Disease
|
January 10, 2020
Knockdown of IL-32 protects PC12 cells against oxygen-glucose deprivation/reoxygenation-induced injury via activation of Nrf2/NF-κB pathway
Hua Yin, Meiyu Wu, Yue Jia
Autoimmunity
|
March 2, 2021
Immune repertoire: Revealing the "real-time" adaptive immune response in autoimmune diseases
Meiyu Wu, Ming Zhao, Haijing Wu, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
July 10, 2024
Cost-effectiveness analysis of first-line serplulimab plus chemotherapy for advanced squamous non-small-cell lung cancer in China: based on the ASTRUM-004 trial
Heng Xiang, Kehui Meng, Meiyu Wu, et al.
Hematological Oncology
|
July 16, 2026
Cost-Effectiveness of Epcoritamab Plus Lenalidomide and Rituximab Versus Lenalidomide and Rituximab for Relapsed/Refractory Follicular Lymphoma: A US Payer Perspective
Yongtao He, Meiyu Wu, Andong Li, et al.
International Journal of Nanomedicine
|
June 27, 2019
Size-dependent cellular uptake and localization profiles of silver nanoparticles
Meiyu Wu, Hongbo Guo, Lin Liu, et al.
Preventive Medicine
|
January 8, 2024
Personalizing age of gastric cancer screening based on comorbidity in China: Model estimates of benefits, affordability and cost-effectiveness optimization
Shuxia Qin, Xuehong Wang, Sini Li, et al.
Future Oncology (London, England)
|
May 10, 2025
Economic evaluation of Erdafitinib as a second-line treatment for advanced metastatic urothelial carcinoma: real-world data from the USA and prospective analysis from China
Andong Li, Meiyu Wu, Ouyang Xie, et al.
BMC Medicine
|
July 27, 2023
Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study
Meiyu Wu, Shuxia Qin, Chongqing Tan, et al.
Page
of 6